IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 203 filers reported holding IMMUNOMEDICS INC in Q2 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $26,423,000 | +275.8% | 310,752 | +56.6% | 0.10% | +197.1% |
| Q2 2020 | $7,032,000 | +2420.4% | 198,432 | +860.6% | 0.04% | +1650.0% |
| Q1 2020 | $279,000 | -77.3% | 20,658 | -67.7% | 0.00% | -60.0% |
| Q1 2019 | $1,229,000 | -71.1% | 63,974 | -78.6% | 0.01% | -73.7% |
| Q4 2018 | $4,256,000 | +0.5% | 298,249 | +46.8% | 0.02% | +26.7% |
| Q3 2018 | $4,233,000 | +49.0% | 203,230 | +69.4% | 0.02% | +25.0% |
| Q2 2018 | $2,841,000 | – | 120,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
| J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
| Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
| SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
| SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
| J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
| BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |